Elham Fakhr

433 total citations
9 papers, 329 citations indexed

About

Elham Fakhr is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Elham Fakhr has authored 9 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Elham Fakhr's work include CAR-T cell therapy research (5 papers), Virus-based gene therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Elham Fakhr is often cited by papers focused on CAR-T cell therapy research (5 papers), Virus-based gene therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Elham Fakhr collaborates with scholars based in Germany, Iran and Latvia. Elham Fakhr's co-authors include Fatemeh Zare, Ladan Teimoori‐Toolabi, Ángel Cid-Arregui, Mansour Poorebrahim, Reza Mahmoudi, Niloufar Mohammadkhani, Mohammad Foad Abazari, Hassan Askari, Vahdat Poortahmasebi and Kayhan Azadmanesh and has published in prestigious journals such as Frontiers in Immunology, Biomedicine & Pharmacotherapy and Immunology.

In The Last Decade

Elham Fakhr

9 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elham Fakhr Germany 7 212 117 79 54 53 9 329
Sergey I. Bayborodin Russia 12 235 1.1× 90 0.8× 60 0.8× 47 0.9× 68 1.3× 23 374
Karim Ghani Canada 12 261 1.2× 96 0.8× 54 0.7× 26 0.5× 142 2.7× 20 381
Valeria Rolih Italy 9 126 0.6× 115 1.0× 154 1.9× 34 0.6× 59 1.1× 10 344
Stephan M. Tirier Germany 6 174 0.8× 88 0.8× 54 0.7× 38 0.7× 30 0.6× 9 311
Miaojin Zhu China 7 130 0.6× 87 0.7× 94 1.2× 46 0.9× 14 0.3× 12 339
Christopher Schliehe Netherlands 11 189 0.9× 97 0.8× 217 2.7× 36 0.7× 16 0.3× 13 378
Laura Borodyansky United States 12 267 1.3× 172 1.5× 84 1.1× 72 1.3× 44 0.8× 28 470
Theodoulakis Christofi Cyprus 7 200 0.9× 102 0.9× 82 1.0× 48 0.9× 21 0.4× 7 370
Matthias Bozza Germany 8 155 0.7× 145 1.2× 97 1.2× 34 0.6× 66 1.2× 13 350
Maggie Bobbin United States 4 385 1.8× 43 0.4× 34 0.4× 89 1.6× 42 0.8× 5 475

Countries citing papers authored by Elham Fakhr

Since Specialization
Citations

This map shows the geographic impact of Elham Fakhr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Fakhr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Fakhr more than expected).

Fields of papers citing papers by Elham Fakhr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Fakhr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Fakhr. The network helps show where Elham Fakhr may publish in the future.

Co-authorship network of co-authors of Elham Fakhr

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Fakhr. A scholar is included among the top collaborators of Elham Fakhr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Fakhr. Elham Fakhr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Volkmar, Michael, Elham Fakhr, Rienk Offringa, et al.. (2023). Identification of TRDV-TRAJ V domains in human and mouse T-cell receptor repertoires. Frontiers in Immunology. 14. 1286688–1286688. 1 indexed citations
2.
Poorebrahim, Mansour, et al.. (2022). Generation of CAR-T cells using lentiviral vectors. Methods in cell biology. 167. 39–69. 9 indexed citations
3.
Poorebrahim, Mansour, et al.. (2021). TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential. Cancer Gene Therapy. 28(6). 581–589. 40 indexed citations
4.
Poorebrahim, Mansour, et al.. (2021). Correction: TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential. Cancer Gene Therapy. 28(6). 738–738. 1 indexed citations
5.
Fakhr, Elham, Fatemeh Zare, Kayhan Azadmanesh, & Ladan Teimoori‐Toolabi. (2021). LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan. Biomedicine & Pharmacotherapy. 143. 112091–112091. 23 indexed citations
6.
Poorebrahim, Mansour, et al.. (2021). Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals. EBioMedicine. 72. 103610–103610. 21 indexed citations
7.
Fakhr, Elham, et al.. (2020). Recent developments in immunotherapy of cancers caused by human papillomaviruses. Immunology. 163(1). 33–45. 22 indexed citations
8.
Poorebrahim, Mansour, Solmaz Sadeghi, Elham Fakhr, et al.. (2019). Production of CAR T-cells by GMP-grade lentiviral vectors: latest advances and future prospects. Critical Reviews in Clinical Laboratory Sciences. 56(6). 393–419. 65 indexed citations
9.
Fakhr, Elham, Fatemeh Zare, & Ladan Teimoori‐Toolabi. (2016). Precise and efficient siRNA design: a key point in competent gene silencing. Cancer Gene Therapy. 23(4). 73–82. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026